Mckesson (MCK) Debt to Equity (2009 - 2026)
Mckesson (MCK) reported Debt to Equity of -$3.69 for Q1 2026, down 10.41% year-over-year from -$4.12 in Q1 2025, and up 49.03% quarter-over-quarter from -$7.24 in Q4 2025.
Mckesson (MCK) Debt to Equity (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Debt to Equity data on file, last reported at -$3.69 in Q1 2026.
- Debt to Equity for Q1 2026 came in at -$3.69, down 10.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.69 (down 10.41% YoY), and the FY2026 annual result was -$3.69, down 10.41% from the prior year.
- Debt to Equity grew to -$3.69 in Q1 2026 per MCK's latest filing, from -$7.24 in the prior quarter.
- Over five years, Debt to Equity peaked at $20.39 in Q2 2025 and troughed at -$7.24 in Q4 2025.
- A 5-year average of -$1.34 and a median of -$3.52 in 2024 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2024 and 2025: Debt to Equity jumped 430.03% in 2024, then tumbled 186.0% in 2025.
- A 5-year view of Debt to Equity shows it stood at -$2.8 in 2022, then decreased by 20.32% to -$3.37 in 2023, then increased by 24.92% to -$2.53 in 2024, then plunged by 186.0% to -$7.24 in 2025, then soared by 49.03% to -$3.69 in 2026.
- Business Quant data shows MCK's Debt to Equity at -$3.69 in Q1 2026, -$7.24 in Q4 2025, and -$5.69 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 0.01 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -3.69 |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.45 |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -3.34 |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 0.72 |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -4.53 |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 1.89 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.26 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 0.46 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.69 |
| Dec 31, 2025 | -7.24 |
| Sep 30, 2025 | -5.69 |
| Jun 30, 2025 | 20.39 |
| Mar 31, 2025 | -3.34 |
| Dec 31, 2024 | -2.53 |
| Sep 30, 2024 | -2.17 |
| Jun 30, 2024 | 15.07 |
| Mar 31, 2024 | -3.52 |
| Dec 31, 2023 | -3.37 |
| Sep 30, 2023 | -3.81 |
| Jun 30, 2023 | -4.57 |
| Mar 31, 2023 | -3.75 |
| Dec 31, 2022 | -2.80 |
| Sep 30, 2022 | -4.49 |
| Jun 30, 2022 | -3.92 |
| Mar 31, 2022 | -3.28 |
| Dec 31, 2021 | -7.57 |
| Sep 30, 2021 | -68.79 |
| Jun 30, 2021 | -159.47 |